Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 6 of 6 entries
Sorted by: Best Match Show Resources per page
Which neurotransmitters modulate corneal sensitivity?.

Clinical & experimental optometry

O'Leary DJ, Nazarian J, Millodot M.
PMID: 23714129
Clin Exp Optom. 1986 May;69(3):108-11. doi: 10.1111/j.1444-0938.1986.tb06799.x.

Corneal sensitivity was assessed before and after applying atropine (0.5, 0.05, 0.005% w/v), pilocarpine (1.0, 0.1%), eserine (0.1, 0.01%) and potassium chloride (171mM). Atropine (0.5 - 0.005%) significantly depressed corneal sensitivity; parasympathomimetics, taken together, significantly increased sensitivity. Exposure to...

Cite
O'Leary DJ, Nazarian J, Millodot M. Which neurotransmitters modulate corneal sensitivity?. Clin Exp Optom. 1986;69(3):108-11doi: 10.1111/j.1444-0938.1986.tb06799.x.
O'Leary, D. J., Nazarian, J., & Millodot, M. (1986). Which neurotransmitters modulate corneal sensitivity?. Clinical & experimental optometry, 69(3), 108-11. https://doi.org/10.1111/j.1444-0938.1986.tb06799.x
O'Leary, D J, et al. "Which neurotransmitters modulate corneal sensitivity?." Clinical & experimental optometry vol. 69,3 (1986): 108-11. doi: https://doi.org/10.1111/j.1444-0938.1986.tb06799.x
O'Leary DJ, Nazarian J, Millodot M. Which neurotransmitters modulate corneal sensitivity?. Clin Exp Optom. 1986 May;69(3):108-11. doi: 10.1111/j.1444-0938.1986.tb06799.x. PMID: 23714129.
Copy Download .nbib Format: NLM
Current pharmacological and surgical treatment of underactive bladder.

Ci ji yi xue za zhi = Tzu-chi medical journal

Jiang YH, Lee CL, Jhang JF, Kuo HC.
PMID: 29296045
Ci Ji Yi Xue Za Zhi. 2017 Oct-Dec;29(4):187-191. doi: 10.4103/tcmj.tcmj_122_17.

Underactive bladder (UAB) or detrusor underactivity (DU) is a common yet still poorly understood urological problem. In addition to true detrusor failure and neuropathy, the inhibitory effects of detrusor contraction by the striated urethral sphincter and the bladder neck...

Cite
Jiang YH, Lee CL, Jhang JF, et al. Current pharmacological and surgical treatment of underactive bladder. Ci Ji Yi Xue Za Zhi. 2017;29(4):187-191doi: 10.4103/tcmj.tcmj_122_17.
Jiang, Y. H., Lee, C. L., Jhang, J. F., & Kuo, H. C. (2017). Current pharmacological and surgical treatment of underactive bladder. Ci ji yi xue za zhi = Tzu-chi medical journal, 29(4), 187-191. https://doi.org/10.4103/tcmj.tcmj_122_17
Jiang, Yuan-Hong, et al. "Current pharmacological and surgical treatment of underactive bladder." Ci ji yi xue za zhi = Tzu-chi medical journal vol. 29,4 (2017): 187-191. doi: https://doi.org/10.4103/tcmj.tcmj_122_17
Jiang YH, Lee CL, Jhang JF, Kuo HC. Current pharmacological and surgical treatment of underactive bladder. Ci Ji Yi Xue Za Zhi. 2017 Oct-Dec;29(4):187-191. doi: 10.4103/tcmj.tcmj_122_17. PMID: 29296045; PMCID: PMC5740689.
Copy Download .nbib Format: NLM
Management of Urinary Incontinence With Underactive Bladder: A Review.

International neurourology journal

Cho KJ, Kim JC.
PMID: 32615672
Int Neurourol J. 2020 Jun;24(2):111-117. doi: 10.5213/inj.2040076.038. Epub 2020 Jun 30.

Urinary incontinence is caused by storage function failure, while underactive bladder (UAB) is caused by a decline in detrusor contractility and voiding dysfunction. As the treatment mechanisms for incontinence and UAB are contrary to each other, it is difficult...

Cite
Cho KJ, Kim JC. Management of Urinary Incontinence With Underactive Bladder: A Review. Int Neurourol J. 2020;24(2):111-117doi: 10.5213/inj.2040076.038.
Cho, K. J., & Kim, J. C. (2020). Management of Urinary Incontinence With Underactive Bladder: A Review. International neurourology journal, 24(2), 111-117. https://doi.org/10.5213/inj.2040076.038
Cho, Kang Jun, and Kim, Joon Chul. "Management of Urinary Incontinence With Underactive Bladder: A Review." International neurourology journal vol. 24,2 (2020): 111-117. doi: https://doi.org/10.5213/inj.2040076.038
Cho KJ, Kim JC. Management of Urinary Incontinence With Underactive Bladder: A Review. Int Neurourol J. 2020 Jun;24(2):111-117. doi: 10.5213/inj.2040076.038. Epub 2020 Jun 30. PMID: 32615672; PMCID: PMC7332822.
Copy Download .nbib Format: NLM
The effectiveness of parasympathomimetics for treating underactive bladder: A systematic review and meta-analysis.

Neurourology and urodynamics

Moro C, Phelps C, Veer V, Clark J, Glasziou P, Tikkinen KAO, Scott AM.
PMID: 34816481
Neurourol Urodyn. 2022 Jan;41(1):127-139. doi: 10.1002/nau.24839. Epub 2021 Nov 24.

AIMS: Biological rationale suggests that parasympathomimetics (cholinergic receptor stimulating agents) could be beneficial for patients with underactive bladder. However, no systematic review with meta-analysis addressing potential benefits or adverse effects exists. The aim of this review was to assess...

Cite
Moro C, Phelps C, Veer V, et al. The effectiveness of parasympathomimetics for treating underactive bladder: A systematic review and meta-analysis. Neurourol Urodyn. 2021;41(1):127-139doi: 10.1002/nau.24839.
Moro, C., Phelps, C., Veer, V., Clark, J., Glasziou, P., Tikkinen, K. A. O., & Scott, A. M. (2022). The effectiveness of parasympathomimetics for treating underactive bladder: A systematic review and meta-analysis. Neurourology and urodynamics, 41(1), 127-139. https://doi.org/10.1002/nau.24839
Moro, Christian, et al. "The effectiveness of parasympathomimetics for treating underactive bladder: A systematic review and meta-analysis." Neurourology and urodynamics vol. 41,1 (2022): 127-139. doi: https://doi.org/10.1002/nau.24839
Moro C, Phelps C, Veer V, Clark J, Glasziou P, Tikkinen KAO, Scott AM. The effectiveness of parasympathomimetics for treating underactive bladder: A systematic review and meta-analysis. Neurourol Urodyn. 2022 Jan;41(1):127-139. doi: 10.1002/nau.24839. Epub 2021 Nov 24. PMID: 34816481.
Copy Download .nbib Format: NLM
Dermatological adverse effects of anti-glaucoma eye drops: a review.

Journal of the European Academy of Dermatology and Venereology : JEADV

Patchinsky A, Petitpain N, Gillet P, Angioi-Duprez K, Schmutz JL, Bursztejn AC.
PMID: 35032359
J Eur Acad Dermatol Venereol. 2022 Jan 15; doi: 10.1111/jdv.17928. Epub 2022 Jan 15.

Many patients are treated for glaucoma. Like other drugs, anti-glaucoma eye drops may induce dermatological adverse effects. We aim to review the dermatological adverse effects secondary to the active agents in anti-glaucoma eye drops through a literature review. In...

Cite
Patchinsky A, Petitpain N, Gillet P, et al. Dermatological adverse effects of anti-glaucoma eye drops: a review. J Eur Acad Dermatol Venereol. 2022;doi: 10.1111/jdv.17928.
Patchinsky, A., Petitpain, N., Gillet, P., Angioi-Duprez, K., Schmutz, J. L., & Bursztejn, A. C. (2022). Dermatological adverse effects of anti-glaucoma eye drops: a review. Journal of the European Academy of Dermatology and Venereology : JEADV, . https://doi.org/10.1111/jdv.17928
Patchinsky, Alexandra, et al. "Dermatological adverse effects of anti-glaucoma eye drops: a review." Journal of the European Academy of Dermatology and Venereology : JEADV vol. (2022). doi: https://doi.org/10.1111/jdv.17928
Patchinsky A, Petitpain N, Gillet P, Angioi-Duprez K, Schmutz JL, Bursztejn AC. Dermatological adverse effects of anti-glaucoma eye drops: a review. J Eur Acad Dermatol Venereol. 2022 Jan 15; doi: 10.1111/jdv.17928. Epub 2022 Jan 15. PMID: 35032359.
Copy Download .nbib Format: NLM
The effectiveness of parasympathomimetics for treating underactive bladder: A systematic review and meta-analysis.

Neurourology and urodynamics

Moro C, Phelps C, Veer V, Clark J, Glasziou P, Tikkinen KAO, Scott AM.
PMID: 34816481
Neurourol Urodyn. 2021 Nov 24; doi: 10.1002/nau.24839. Epub 2021 Nov 24.

AIMS: Biological rationale suggests that parasympathomimetics (cholinergic receptor stimulating agents) could be beneficial for patients with underactive bladder. However, no systematic review with meta-analysis addressing potential benefits or adverse effects exists. The aim of this review was to assess...

Cite
Moro C, Phelps C, Veer V, et al. The effectiveness of parasympathomimetics for treating underactive bladder: A systematic review and meta-analysis. Neurourol Urodyn. 2021;doi: 10.1002/nau.24839.
Moro, C., Phelps, C., Veer, V., Clark, J., Glasziou, P., Tikkinen, K. A. O., & Scott, A. M. (2021). The effectiveness of parasympathomimetics for treating underactive bladder: A systematic review and meta-analysis. Neurourology and urodynamics, . https://doi.org/10.1002/nau.24839
Moro, Christian, et al. "The effectiveness of parasympathomimetics for treating underactive bladder: A systematic review and meta-analysis." Neurourology and urodynamics vol. (2021). doi: https://doi.org/10.1002/nau.24839
Moro C, Phelps C, Veer V, Clark J, Glasziou P, Tikkinen KAO, Scott AM. The effectiveness of parasympathomimetics for treating underactive bladder: A systematic review and meta-analysis. Neurourol Urodyn. 2021 Nov 24; doi: 10.1002/nau.24839. Epub 2021 Nov 24. PMID: 34816481.
Copy Download .nbib Format: NLM
Showing 1 to 6 of 6 entries